
Healthcare · NSE / BSE
Paras Healthcare Limited, incorporated in December 1987 as Arbian Frozen Foods Private Limited, is a clinical specialty-focused hospital platform providing tertiary and quaternary healthcare services across North India, Bihar and Jharkhand under the “Paras Health” brand. As of March 31, 2026, the company operated eight hospitals with a combined capacity of 2,211 beds across Gurugram, Panchkula, Patna, Darbhanga, Kanpur, Udaipur, Ranchi and Srinagar. Its key clinical specialties include cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics and sports injury, and renal sciences, collectively contributing 74.70% of revenue in Fiscal 2026. With more than 20 years of operating experience, Paras Healthcare follows a balanced expansion strategy covering mature, emerging and new hospitals. The company plans to add a 300-bed hospital in Gurugram and a 500-bed hospital in Ludhiana, taking its total bed capacity to 3,011 by March 2028. As of March 31, 2026, the company had 4,670 employees, including 1,011 doctors and 1,665 nurses.
Price Band
₹660 – ₹693
Issue Size
₹1450 Cr
Lot Size
21 shares
GMP
+1.9%
Est. Listing
₹706
at current GMP
Subscribed
2.34x
overall
Open
21 Oct 2026
Close
23 Oct 2026
Allotment
26 Oct 2026
Refund
27 Oct 2026
Demat Credit
28 Oct 2026
Listing
28 Oct 2026
Last updated: 28 Oct 2026
Current Premium
Issue Price (Upper)
₹693
Band: ₹660 – ₹693
Estimated Listing Price
₹706
Upper price + GMP
Lot Size
21 shares
Min investment ₹14,553
Estimated Profit / Lot
₹273
21 × ₹13
Grey Market Premium trend
—
▼ 75 today
Updated 3 days ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 5 Oct 2026 | — | 0.0% | ₹693 |
| 14 Oct 2026 | +₹75 | 10.8% | ₹75 |
| 14 Oct 2026 | — | 0.0% | ₹693 |
| 14 Oct 2026 | +₹51 | 7.4% | ₹51 |
| 15 Oct 2026 | +₹115 | 16.6% | ₹808 |
| 16 Oct 2026 | +₹97 | 14.0% | ₹790 |
| 17 Oct 2026 | +₹96 | 13.8% | ₹789 |
| 18 Oct 2026 | +₹92 | 13.3% | ₹785 |
| 19 Oct 2026 | +₹78 | 11.3% | ₹771 |
| 20 Oct 2026 | +₹50 | 7.2% | ₹743 |
| 21 Oct 2026 | +₹25 | 3.6% | ₹718 |
| 22 Oct 2026 | +₹13 | 1.9% | ₹706 |
| 23 Oct 2026 | +₹11 | 1.6% | ₹704 |
| 23 Oct 2026 | +₹12 | 1.7% | ₹705 |
| 25 Oct 2026 | +₹12 | 1.7% | ₹705 |
| 27 Oct 2026 | +₹16 | 2.3% | ₹709 |
| 28 Oct 2026 | +₹13 | 1.9% | ₹706 |
GMP is unofficial market data. Not a guarantee of listing performance.
Paras Healthcare Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹1,450 Crores. The shares are offered at a price band of ₹660 to ₹693 per equity share on NSE and BSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 21 shares (approx. ₹14,553 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Link Intime India Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2026-10-28, while un-allotted funds or UPI block mandates will be released on 2026-10-27.
The latest grey market premium for Paras Healthcare Limited IPO is ₹13, which indicates an expected listing price of ₹706.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.